Helga Salvesen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Monstad Sissel Evy; Knudsen Anette; Salvesen Helga B; Aarseth Jan H; Vedeler Christian A
Onconeural antibodies in sera from patients with various types of tumours.
Engelsen Ingeborg B; Akslen Lars A; Salvesen Helga B
Biologic markers in endometrial cancer treatment.
Ni Bhriain Hannah; Trovik Jone; Wik Elisabeth; Stefansson Ingunn M; Akslen Lars A; Salvesen Helga B; Staff Anne Cathrine
Plasma calprotectin concentrations in women with endometrial carcinoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Helga Salvesen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Monstad Sissel Evy; Knudsen Anette; Salvesen Helga B; Aarseth Jan H; Vedeler Christian A
Onconeural antibodies in sera from patients with various types of tumours.
Cancer immunology, immunotherapy : CII 2009;58(11):1795-800.
2009: Engelsen Ingeborg B; Akslen Lars A; Salvesen Helga B
Biologic markers in endometrial cancer treatment.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2009;117(10):693-707.
2009: Ni Bhriain Hannah; Trovik Jone; Wik Elisabeth; Stefansson Ingunn M; Akslen Lars A; Salvesen Helga B; Staff Anne Cathrine
Plasma calprotectin concentrations in women with endometrial carcinoma.
Gynecologic oncology 2009;114(3):491-5.
2009: Albrektsen Grethe; Heuch Ivar; Wik Elisabeth; Salvesen Helga B
Prognostic impact of parity in 493 uterine sarcoma patients.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(6):1062-7.
2009: Albrektsen Grethe; Heuch Ivar; Wik Elisabeth; Salvesen Helga B
Parity and time interval since childbirth influence survival in endometrial cancer patients.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):665-9.
2009: Salvesen H B; Carter S L; Mannelqvist M; Dutt A; Getz G; Stefansson I M; Raeder M B; Sos M L; Engelsen I B; Trovik J; Wik E; Greulich H; Bø T H; Jonassen I; Thomas R K; Zander T; Garraway L A; Oyan A M; Sellers W R; Kalland K H; Meyerson M; Akslen L A; Beroukhim R
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(12):4834-9.
2009: Mannelqvist Monica; Stefansson Ingunn; Salvesen Helga B; Akslen Lars A
Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma.
Histopathology 2009;54(2):174-83.
2008: Hoshida Yujin; Villanueva Augusto; Kobayashi Masahiro; Peix Judit; Chiang Derek Y; Camargo Amy; Gupta Supriya; Moore Jamie; Wrobel Matthew J; Lerner Jim; Reich Michael; Chan Jennifer A; Glickman Jonathan N; Ikeda Kenji; Hashimoto Masaji; Watanabe Goro; Daidone Maria G; Roayaie Sasan; Schwartz Myron; Thung Swan; Salvesen Helga B; Gabriel Stacey; Mazzaferro Vincenzo; Bruix Jordi; Friedman Scott L; Kumada Hiromitsu; Llovet Josep M; Golub Todd R
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
The New England journal of medicine 2008;359(19):1995-2004.
2008: Engelsen Ingeborg B; Stefansson Ingunn M; Akslen Lars A; Salvesen Helga B
GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.
American journal of obstetrics and gynecology 2008;199(5):543.e1-7.
2008: Dutt Amit; Salvesen Helga B; Chen Tzu-Hsiu; Ramos Alex H; Onofrio Robert C; Hatton Charlie; Nicoletti Richard; Winckler Wendy; Grewal Rupinder; Hanna Megan; Wyhs Nicolas; Ziaugra Liuda; Richter Daniel J; Trovik Jone; Engelsen Ingeborg B; Stefansson Ingunn M; Fennell Tim; Cibulskis Kristian; Zody Michael C; Akslen Lars A; Gabriel Stacey; Wong Kwok-Kin; Sellers William R; Meyerson Matthew; Greulich Heidi
Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(25):8713-7.
2008: Engelsen I B; Mannelqvist M; Stefansson I M; Carter S L; Beroukhim R; Øyan A M; Otte A P; Kalland K H; Akslen L A; Salvesen H B
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
British journal of cancer 2008;98(10):1662-9.
2008: Salvesen Helga B
[Late, but good]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2008;128(6):678.
2008: Engelsen Ingeborg B; Stefansson Ingunn M; Beroukhim Rameen; Sellers William R; Meyerson Matthew; Akslen Lars A; Salvesen Helga B
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.
International journal of oncology 2008;32(2):307-16.
2007: Petersen Kjell; Oyan Anne Margrete; Rostad Kari; Olsen Sue; Bø Trond Hellem; Salvesen Helga B; Gjertsen Bjørn Tore; Bruserud Oystein; Halvorsen Ole Johan; Akslen Lars Andreas; Steen Vidar M; Jonassen Inge; Kalland Karl-Henning
Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization.
Analytical biochemistry 2007;366(1):46-58.
2006: Engelsen Ingeborg B; Stefansson Ingunn; Akslen Lars A; Salvesen Helga B
Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas.
American journal of obstetrics and gynecology 2006;195(4):979-86.
2006: Knudsen Anette; Monstad Sissel E; Dørum Anne; Lønning Per E; Salvesen Helga B; Drivsholm Lars; Aarseth Jan H; Vedeler Christian A
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.
Cancer immunology, immunotherapy : CII 2006;55(10):1280-4.
2006: Monstad S E; Storstein A; Dørum A; Knudsen A; Lønning P E; Salvesen H B; Aarseth J H; Vedeler C A
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
Clinical and experimental immunology 2006;144(1):53-8.
2006: Stefansson Ingunn M; Salvesen Helga B; Akslen Lars A
Vascular proliferation is important for clinical progress of endometrial cancer.
Cancer research 2006;66(6):3303-9.
2006: Stefansson Ingunn M; Salvesen Helga B; Akslen Lars A
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients.
International journal of cancer. Journal international du cancer 2006;118(5):1227-33.
2006: Bachmann Ingeborg M; Halvorsen Ole J; Collett Karin; Stefansson Ingunn M; Straume Oddbjørn; Haukaas Svein A; Salvesen Helga B; Otte Arie P; Akslen Lars A
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(2):268-73.
2005: Salvesen Helga B; Iversen Ole Erik; Tropé Claes
[Molecular diagnostic techniques in gynaecologic cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(22):3120-3.
2005: Sagen J V; Baumann M E; Salvesen H B; Molven A; Søvik O; Njølstad P R
Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(8):1012-5.
2005: Salvesen Helga B; Kumar Rajiv; Stefansson Ingunn; Angelini Sabrina; MacDonald Nicola; Smeds Johanna; Jacobs Ian J; Hemminki Kari; Das Soma; Akslen Lars A
Low frequency of BRAF and CDKN2A mutations in endometrial cancer.
International journal of cancer. Journal international du cancer 2005;115(6):930-4.
2004: Salvesen Helga B; Stefansson Ingunn; Kretzschmar Ellen I; Gruber Paula; MacDonald Nicola D; Ryan Andy; Jacobs Ian J; Akslen Lars A; Das Soma
Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
International journal of oncology 2004;25(6):1615-23.
2004: Salvesen Helga B; Trovik Jone; Børdahl Per E
[Staffing and emergency service in Norwegian obstetrics and gynecology departments]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(21):2780-2.
2004: Macdonald N D; Salvesen H B; Ryan A; Malatos S; Stefansson I; Iversen O E; Akslen L A; Das S; Jacobs I J
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(5):957-65.
2004: Stefansson I M; Salvesen H B; Immervoll H; Akslen L A
Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
Histopathology 2004;44(5):472-9.
2004: Stefansson Ingunn M; Salvesen Helga B; Akslen Lars A
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1242-52.
2003: Salvesen Helga B; Gulluoglu Mine G; Stefansson Ingunn; Akslen Lars A
Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(11):1011-8.
2003: Halford Sarah E R; Sawyer Elinor J; Lambros Maryou B; Gorman Patricia; Macdonald Nicola D; Talbot Ian C; Foulkes William D; Gillett Cheryl E; Barnes Diana M; Akslen Lars A; Lee Kwok; Jacobs Ian J; Hanby Andrew M; Ganesan Trivadi S; Salvesen Helga B; Bodmer Walter F; Tomlinson Ian P M; Roylance Rebecca R
MSI-low, a real phenomenon which varies in frequency among cancer types.
The Journal of pathology 2003;201(3):389-94.
2003: Alexander-Sefre Farhad; Salvesen Helga B; Ryan Andy; Singh Naveena; Akslen Lars A; MacDonald Nicolla; Wilbanks George; Jacobs Ian J
Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.
Gynecologic oncology 2003;91(1):218-25.
2002: Straume Oddbjørn; Chappuis Pierre O; Salvesen Helga B; Halvorsen Ole J; Haukaas Svein A; Goffin John R; Bégin Louis R; Foulkes William D; Akslen Lars A
Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.
Cancer research 2002;62(23):6808-11.
2002: Salvesen Helga B; Akslen Lars A
Molecular pathogenesis and prognostic factors in endometrial carcinoma.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(10):673-89.
2002: Salvesen Helga B
[Mass screening against endometrial carcinoma]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(18):1774-6.
2002: Salvesen Helga B; Stefansson Ingunn; Kalvenes May Britt; Das Soma; Akslen Lars A
Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma.
Cancer 2002;94(8):2185-91.
2002: Stefansson Ingunn; Akslen Lars A; MacDonald Nicola; Ryan Andy; Das Soma; Jacobs Ian J; Salvesen Helga B
Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):138-43.
2001: Salvesen H B
[Routine follow up after treatment for gynecological cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(10):1253-5.
2001: Salvesen H B
[Role of lymphadenectomy in the surgery of gynecologic cancer]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(10):1240-5.
2001: Salvesen H B; MacDonald N; Ryan A; Jacobs I J; Lynch E D; Akslen L A; Das S
PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.
International journal of cancer. Journal international du cancer 2001;91(1):22-6.
2000: Navari J R; Roland P Y; Keh P; Salvesen H B; Akslen L A; Iversen O E; Das S; Kothari R; Howey S; Phillips B
Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):4026-32.
2000: Salvesen H B; MacDonald N; Ryan A; Iversen O E; Jacobs I J; Akslen L A; Das S
Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3607-13.
2000: MacDonald N D; Salvesen H B; Ryan A; Iversen O E; Akslen L A; Jacobs I J
Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas.
Cancer research 2000;60(6):1750-2.
2000: Salvesen H B; Das S; Akslen L A
Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):153-9.
1999: Salvesen H B; Akslen L A
Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
International journal of cancer. Journal international du cancer 1999;84(5):538-43.
1999: Straume O; Salvesen H B; Akslen L A
Angiogenesis is prognostically important in vertical growth phase melanomas.
International journal of oncology 1999;15(3):595-9.
1999: Salvesen H B; Iversen O E; Akslen L A
Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1382-90.
1998: Salvesen H B; Iversen O E; Akslen L A
Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2779-85.
1998: Salvesen H B; Iversen O E; Akslen L A
Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Cancer 1998;83(5):956-64.
1998: Salvesen H B; Iversen O E; Akslen L A
Independent prognostic importance of microvessel density in endometrial carcinoma.
British journal of cancer 1998;77(7):1140-4.
1998: Salvesen H B; Akslen L A; Albrektsen G; Iversen O E
Poorer survival of nulliparous women with endometrial carcinoma.
Cancer 1998;82(7):1328-33.
1997: Salvesen H B; Akslen L A; Iversen T; Iversen O E
Recurrence of endometrial carcinoma and the value of routine follow up.
British journal of obstetrics and gynaecology 1997;104(11):1302-7.
1993: Svanes C; Salvesen H; Stangeland L; Svanes K; Søreide O
Perforated peptic ulcer over 56 years. Time trends in patients and disease characteristics.
Gut 1993;34(12):1666-71.
1993: Akslen L A; Myking A O; Salvesen H; Varhaug J E
Prognostic impact of EGF-receptor in papillary thyroid carcinoma.
British journal of cancer 1993;68(4):808-12.
1992: Salvesen H; Njølstad P R; Akslen L A; Albrektsen G; Søreide O; Varhaug J E
Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system.
The European journal of surgery = Acta chirurgica 1992;158(11-12):583-9.
1992: Akslen L A; Myking A O; Salvesen H; Varhaug J E
Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):44-51.
1991: Salvesen H; Njølstad P R; Akslen L A; Albrektsen G; Viste A; Søreide O; Varhaug J E
Thyroid carcinoma: results from surgical treatment in 211 consecutive patients.
The European journal of surgery = Acta chirurgica 1991;157(9):521-6.
1990: Svanes C; Salvesen H; Bjerke Larssen T; Svanes K; Søreide O
Trends in and value and consequences of radiologic imaging of perforated gastroduodenal ulcer. A 50-year experience.
Scandinavian journal of gastroenterology 1990;25(3):257-62.
1989: Svanes C; Salvesen H; Espehaug B; Søreide O; Svanes K
A multifactorial analysis of factors related to lethality after treatment of perforated gastroduodenal ulcer. 1935-1985.
Annals of surgery 1989;209(4):418-23.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Helga Salvesen

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Geographic Areas

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Helga Salvesen (preview)

All Publications